Monograph: Reassessment of human cancer risk of aldrin/dieldrin

Toxicology Letters

Volumn 109, Issue 3, 1999, Pages 123-186

  Stevenson, Donald E ^a   Walborg Jr , Earl F ^a   North, D Warner ^b   Sielken Jr , Robert L ^c   Ross, C E ^e   Wright, Alan S ^e   Xu, Yong ^d   Kamendulis, Lisa M ^d   Klaunig, James E ^d  

^a Dermigen Inc   (United States)

^b NorthWorks Inc   (United States)

^c Sielken & Associates Inc   (United States)

^d INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e NONE

Author keywords

Aldrin; Antioxidant defense; Dieldrin; Epidemiology; Hepatocarcinogenesis; Human cancer risk; Mechanism of action; Mode of action; Mouse liver tumors; Organochlorine insecticides; Oxidative stress

Indexed keywords

ALDRIN; ALPHA TOCOPHEROL; ANTIOXIDANT; CARCINOGEN; DIELDRIN; ORGANOCHLORINE INSECTICIDE; REACTIVE OXYGEN METABOLITE;

CANCER RISK; ENVIRONMENTAL PROTECTION; HUMAN; INDUSTRIAL WORKER; LIPID LIVER LEVEL; LIPID PEROXIDATION; LIVER CARCINOGENESIS; NONHUMAN; OCCUPATIONAL EXPOSURE; OXIDATIVE STRESS; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT;

EID: 0032837475     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-4274(99)00132-0     Document Type: Article

References (297)

1. Ahotupa, M., Bereziat, J.C., Mantyla, E., Bartsch, H., 1993. Dietary fat- and phenobarbital-induced alterations in hepatic antioxidant functions of mice. Carcinogenesis 14, 1225-1228.
2. Amaoteng-Adjepong, Y., Sathiakumar, N., Delzell, E., Cole, P., 1995. Mortality among workers at a pesticide manufacturing plant. J. Occup. Environ. Med. 37, 471-478.
3. Ames, B.N., Gold, L.S., 1990. Chemical carcinogenesis: too many rodent carcinogens. Proc. Natl. Acad. Sci. U.S.A. 87, 7772-7776.
4. Annau, E., 1953. Estimation of pentose nucleic acid and desoxypentose nucleic acid in the liver and brain tissue of mice following the feeding of the insecticide aldrin. Can. J. Biochem. Physiol. 32, 178.
5. ATSDR, 1993a. Toxicological profile for aldrin/dieldrin. Agency for Toxic Substances and Disease Registry, Atlanta, GA.
6. ATSDR, 1993b. Toxicological profile for heptachlor/heptachlor epoxide. Agency for Toxic Substances and Disease Registry, Atlanta, GA.
7. ATSDR, 1994. Toxicological profile for chlordane (update). Agency for Toxic Substances and Disease Registry, Syracuse Research Corporation, Syracuse, NY.
8. Auclair, C., de Prost, D., Hakim, J., 1978. Superoxide anion production by liver microsomes from phenobarbital treated rats. Biochem. Pharmacol. 27, 355-358.
9. Aust, S.D., Chignell, C.F., Bray, T.M., Kalyanaraman, B., Mason, R.P., 1993. Free radicals in toxicology. Toxicol. Appl. Pharmacol. 120, 168-178.
10. Bachowski, S., Xu, Y., Baker, T.K., Stevenson, D.E., Walborg, E.F. Jr, Klaunig, J.E., 1995. The potential role of oxidative stress in nongenotoxic hepatocarcinogenesis in the mouse liver. In: McClain, R.M., Slaga, T.J., LeBoeuf, R., Pitot, H. (Eds.), Growth Factors and Tumor Promotion: Implications for Risk Assessment. Wiley-Liss, New York, pp. 385-396.
11. Bachowski, S., Kolaja, K.L., Xu, Y., Ketcham, C.A., Stevenson, D.E., Walborg, E.F. Jr, Klaunig, J.E., 1997. Role of oxidative stress in the mechanism of dieldrin's hepatotoxicity. Ann. Clin. Lab. Sci. 27, 196-209.
12. Bachowski, S., Xu, Y., Stevenson, D.E., Walborg, E.F. Jr, Klaunig, J.E., 1998. Role of oxidative stress in the selective toxicity of dieldrin in the mouse liver. Toxicol. Appl. Pharmacol. 150, 301-309.
13. Bagchi, D., Bagchi, M., Hassoun, E., Moser, J., Stohs, S.J., 1993. Effects of carbon tetrachloride, menadione, and paraquat on the urinary excretion of malondialdehyde, formaldehyde, acetaldehyde, and acetone in rats. J. Biochem. Toxicol. 8, 101-106.
14. Baker, T.K., Bachowski, S., Stevenson, D.E., Walborg, E.F. Jr, Klaunig, J.E., 1995. Modulation of gap junctional intercellular communication in rodent, monkey and human hepatocyte by nongenotoxic compounds. In: McClain, R.M., Slaga, T.J., LeBoeuf, R., Pitot, H. (Eds.), Growth Factors and Tumor Promotion: Implications for Risk Assessment. Wiley-Liss, New York, pp. 71-80.
15. Baldwin, M.K., Robinson, J., Parke, D.V., 1972. A comparison of the metabolism of HEOD (dieldrin) in the CF1 mouse with that in the CFE rat. Food Cosmet. Toxicol. 10, 333-351.
16. Bandyopadhyay, S.K., Tiwari, R.K., Mitra, A., Mukherjee, B., Banerjee, A., Chatterjee, G.C., 1982. Effects of L-ascorbic acid supplementation on dieldrin toxicity in rats. Arch. Toxicol. 50, 227-232.
17. Bankson, D.D., Kestin, M., Rifai, N., 1993. Role of free radicals in cancer and atherosclerosis. Clin. Lab. Med. 13, 463-480.
18. Bauer-Hofmann, R., Buchmann, A., Wright, A.S., Schwarz, M., 1990. Mutations in the Ha-ras proto-oncogene in spontaneous and chemically induced liver tumours of the CF1 mouse. Carcinogenesis 11, 1875-1877.
19. Bauer-Hofmann, R., Buchmann, A., Mahr, J., Kress, S., Schwarz, M., 1992. The tumour promoters dieldrin and phenobarbital increase the frequency of c-Ha-ras wild-type, but not of c-Ha-ras mutated focal liver lesions in male C3H/He mice. Carcinogenesis 13, 477-481.
20. Bayly, A.C., Roberts, R.A., Dive, C., 1994. Suppression of liver cell apoptosis in vitro by the non-genotoxic hepatocarcinogen and peroxisome proliferator nafenopin. J. Cell Biol. 125, 197-203.
21. Beal, D.D., 1990. Use of mouse liver tumor data in risk assessments performed by the U.S. Environmental Protection Agency. In: Stevenson, D.E., McClain, R.M., Popp, J.A., Slaga, T.J., Ward, J.M., Pitot, H.C. (Eds.), Mouse Liver Carcinogenesis: Mechanisms and Species Comparisons. Wiley-Liss, New York, pp. 5-18.
22. Bergelson, S., Pinkus, R., Daniel, V., 1994. Intracellular glutathione levels regulate fos/jun induction and activation of glutathione S-transferase gene expression. Cancer Res. 54, 36-40.
23. Bohm, N., Noltemeyer, N., 1981. Excessive reversible phenobarbital-induced nuclear DNA-polyploidization in the growing mouse liver. Histochemistry 72, 63-74.
24. Borek, C., 1991. Free-radical processes in multistage carcinogenesis. Free Radic. Res. Commun. 12-13, 745-750.
25. Brawn, M.K., Chiou, W.J., Leach, K.L., 1995. Oxidant-induced activation of protein kinase C in UC11MG cells. Free Radic. Res. 22, 23-37.
26. Breimer, L.H., 1990. Molecular mechanisms of oxygen radical carcinogenesis and mutagenesis: the role of DNA base damage. Mol. Carcinog. 3, 188-197.
27. Brown, D.P., 1992. Mortality of workers employed at organochlorine pesticide manufacturing plants - an update. Scand. J. Environ. Health 18, 155-161.
28. Brown, V.K.H., Hunter, C.G., Richardson, A., 1964. A blood test diagnostic of exposure to aldrin and dieldrin. Br. J. Ind. Med. 21, 283-286.
29. Bucher, J.R., Shackelford, G.G., Haseman, J.K., Johnson, J.D., Kurts, P.J., Persing, R.L., 1994. Carcinogenicity studies of oxazepam in mice. Fundam. Appl. Toxicol. 23, 280-297.
30. Buchmann, A., Mahr, J., Bauer-Hofmann, R., Schwarz, M., 1989. Mutations at codon 61 of the Ha-ras proto-oncogene in precancerous liver lesions of the B6C3F1 mouse. Mol. Carcinog. 2, 121-125.
31. Buchmann, A., Bauer-Hofmann, R., Mahr, J., Drinkwater, N.R., Luz, A., Schwarz, M., 1991. Mutational activation of the c-Ha-ras gene in liver tumors of different rodent strains: correlation with susceptibility to hepatocarcinogenesis. Proc. Natl. Acad. Sci. U.S.A. 88, 911-915.
32. Burke, M.D., Mayer, R.T., 1974. Ethoxyresorufin: direct fluorimetric assay of a microsomal O-dealkylation which is preferentially inducible by 3-methylcholanthrene. Drug Metab. Dispos. 2, 583-588.
33. Büsser, M.T., Lutz, W.K., 1987. Stimulation of DNA synthesis in rat and mouse liver by various tumor promoters. Carcinogenesis 8, 1433-1437.
34. Butler, W.H., 1996. A review of the hepatic tumors related to mixed-function oxidase induction in the mouse. Toxicol. Pathol. 24, 484-492.
35. Butterworth, B.E., 1990. Consideration of both genotoxic and nongenotoxic mechanisms in predicting carcinogenic potential. Mutat. Res. 239, 117-132.
36. Butterworth, B.E., Sprankle, C.S., Goldsworthy, S.M., Wilson, D.M., Goldsworthy, T.L., 1994. Expression of myc, fos, and Ha-ras in the livers of furan-treated F344 rats and B6C3F1 mice. Mol. Carcinog. 9, 24-32.
37. Calabrese, E.J., Baldwin, L.A., 1998. Hormesis as a biological hypothesis. Environ. Health Perspect. 106, 357-362.
38. Carmichael, N.G., Enzmann, H., Pate, L, Waechter, F., 1997. The significance of mouse liver tumor formation for carcinogenic risk assessment: results and conclusions from a survey of ten years of testing by the agrochemical industry. Environ. Health Perspect. 105, 1196-1203.
39. Cerutti, P.A., Trump, B.F., 1991. Inflammation and oxidative stress in carcinogenesis. Cancer Cells 3, 1-7.
40. Charpentier, A., Groves, S., Simmons-Menchaca, M., Turley, J., Zhao, B., Sanders, B.G., Kline, K., 1993. RRR-α-tocopheryl succinate inhibits proliferation and enhances secretion of transforming growth factor β (TGF-β) by human breast cancer cells. Nutr. Can. 19, 225-239.
41. Chaudhary, A.K., Nokubo, M., Marnett, L.J., Blair, I.A., 1994. Analysis of the malondialdehyde-2°-deoxyguanosine adduct in rat liver DNA by gas chromatography/electron capture negative chemical ionization mass spectrometry. Biol. Mass Spectrom. 23, 457-464.
42. Chen, L.H., 1989. Interaction of vitamin E and ascorbic acid (Review). In Vivo 3, 199-210.
43. Clayson, D.B., Mehta, R., Iverson, F., 1994. Oxidative DNA damage-the effects of certain genotoxic and operationally non-genotoxic carcinogens. Mutat. Res. 317, 25-42.
44. Clemmesen, J., 1975. Phenobarbitone, liver tumours, and thorotrast. Lancet 1, 37-38.
45. Clemmesen, J., Fuglsang-Frederiksen, V., Plum, C.M., 1974. Are anticonvulsants oncogenic? Lancet 1, 705-707.
46. Cohen, S.M., Ellwein, L.B., 1990. Cell proliferation in carcinogenesis. Science 249, 1007-1011.
47. Cohen, S.M., Ellwein, L.B., 1991. Genetic errors, cell proliferation, and carcinogenesis. Cancer Res. 51, 6493-6505.
48. Conolly, R.G., Beck, B.D., Goodman, J.I., 1999. Stimulating research to improve the scientific basis of risk assessment. Toxicol. Sci. 49, 1-4.
49. CEQ, 1989. Environmental Trends. Council on Environmental Quality, Executive Office of the President, Washington, DC.
50. Coveney, P., Highfield, R., 1995. Frontiers of Complexity: The Search for Order in a Chaotic World. Fawcett Columbine, New York.
51. Cueto, C. Jr, Hayes, W.J. Jr, 1962. The detection of dieldrin metabolites in human urine. J. Agric. Food Chem. 10, 366-369.
52. Cueto, C. Jr, Biros, F.J., 1967. Chlorinated insecticides and related materials in human urine. Toxicol. Appl. Pharmacol. 10, 261-269.
53. Cunningham, M.L., Foley, J., Maronpot, R.R, Mathews, H.B., 1991. Correlation of hepatocellular proliferation with hepatocarcinogenicity induced by the mutagenic noncarcinogen: carcinogen pair-2,6- and 2,4-diaminotoulene. Toxicol. Appl. Pharmacol. 107, 562-567.
54. Cunningham, M.L., Elwell, M.R., Mathews, H.B., 1994. Relationship of carcinogenicity and cellular proliferation induced by mutagenic noncarcinogens vs carcinogens. III. Organophosphate pesticides vs tris(2,3-dibromo-propyl)phosphate. Fundam. Appl. Toxicol. 23, 363-369.
55. Cutler, R.G., 1984. Antioxidants, aging, and longevity. Free Radie. Biol. 6, 371-428.
56. Davis, K.J., 1974. Written Statement, Shell Exhibit (Statement of Testimony for Aldrin/Dieldrin Hearings, Suspension Phase). US EPA Suspension Hearings on aldrin and dieldrin, Washington DC, September, 1974.
57. Davis, K.J., Fitzhugh, O.G., 1962. Tumorigenic potential of aldrin and dieldrin for mice. Toxicol. Appl. Pharmacol. 4, 187-189.
58. de Jong, G., 1991. Long-term health effects of aldrin and dieldrin. A study of exposure, health effects and mortality of workers engaged in the manufacture and formulation of the insecticides aldrin and dieldrin, Toxicol. Lett., Suppl., 1-206.
59. de Jong, G., Swaen, G.M., Slangen, J.J., 1997. Mortality of workers exposed to dieldrin and aldrin: a retrospective cohort study. Occup. Environ. Med. 54, 702-707.
60. de Vlieger, M., Robinson, J., Baldwin, M.K., Crabtree, A.N., Van Dijk, M.C., 1968. The organochlorine insecticide content of human tissues. Arch. Environ. Health 17, 759-767.
61. Dean, B.J., Doak, S.M.A., Somerville, H., 1975. The potential mutagenicity of dieldrin (HEOD) in mammals. Food Cosmet. Toxicol. 13, 317-323.
62. Deichmann, W.B., MacDonald, W.E., 1977. Organochlorine pesticides and liver cancer deaths in the United States, 1930-1972. Ecotoxicol. Environ. Saf. 1, 89-110.
63. Deichmann, W.B., MacDonald, W.E., Blum, E., Bevilacqua, M., Radomski, J., Keplinger, M., Balkus, M., 1970. Tumorigenicity of aldrin, dieldrin, and endrin in the albino rat. Ind. Med. 39, 426-434.
64. DHEW, 1969. Report of the Secretary's Commission on Pesticides and Their Relationship to Environmental Health. US Department of Health, Education and Welfare, Washington, DC.
65. DHHS, 1997. Health United States 1996-97 and Injury Chartbook. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Health Statistics. US Government Printing Office, Washington, DC.
66. Ditraglia, D., Brown, D.P., Namekata, T., Iverson, N., 1981. Mortality study of workers employed at organochlorine pesticide manufacturing plants. Scand. J. Work Environ. Health 4, 140-146.
67. Diwan, B.A., Rice, J.M., Ward, J.M., 1986. Tumor-promoting activity of benzodiazepine tranquilizers, diazepam and oxazepam, in mouse liver. Carcinogenesis 7, 789-794.
68. Diwan, B.A., Ward, J.M., Rice, J.M., 1991. Modification of liver tumor development in rodents. Prog. Exp. Tumor Res. 33, 76-107.
69. Dix, K.M., 1981. An investigation into some aspects of the pathogenesis of rodent liver cell neoplasms. Doctoral Thesis, University of Surrey, Guildford, UK.
70. Doll, R., Peto, R., 1981. The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. J. Natl. Cancer Inst. 66, 1192-1308.
71. Dragan, Y., Klaunig, J., Maronpot, R., Goldsworthy, T., 1998. Mechanisms of susceptibility to mouse liver carcinogenesis. Toxicol. Sci. 41, 3-7.
72. Drinkwater, N.R., Bennett, L.M., 1991. Genetic control of carcinogenesis in experimental animals. Prog. Exp. Tumor Res. 33, 1-20.
73. Druckery, H., 1967. Quantitative aspects of chemical carcinogenesis. U.I.C.C. Monograph Ser. 7, 60-78.
74. ECETOC, 1982. Hepatocarcinogenesis in laboratory rodents, relevance for man, Monograph No. 4. European Chemical Industry, Ecology and Toxicology Centre, Brussels.
75. Edwards, J.W., Priestly, B.G., 1994. Effect of occupational exposure to aldrin on urinary D-glucaric acid, plasma dieldrin, and lymphocyte sister chromatid exchange. Int. Arch. Occup. Environ. Health 66, 229-234.
76. Eldridge, S.R., Goldsworthy, T.L., Popp, J.A., Butterworth, B.E., 1992. Mitogenic stimulation of hepatocellular proliferation in rodents following 1,4-dichlorobenzene administration. Carcinogenesis 13, 409-415.
77. Enomoto, K., Farber, E., 1982. Kinetics of phenotypic maturation of remodeling hyperplastic nodules during liver carcinogenesis. Cancer Res. 42, 2330-2338.
78. Enzmann, H., Bannasch, P., 1987. Potential significance of phenotypic heterogeneity of focal lesions at different stages in hepatocarcinogenesis. Carcinogenesis 8, 1607-1612.
79. EPA, 1974. Consolidated aldrin/dieldrin hearing. US Environmental Protection Agency, Federal Register 39, Washington, DC, pp. 37246-37251.
80. EPA, 1986. Guidelines for Carcinogen Risk Assessment. US Environmental Protection Agency, Federal Register 51, Washington, DC, pp. 33992-34003.
81. EPA, 1987. Carcinogenicity Assessment of Aldrin and Dieldrin. US Environmental Protection Agency, Carcinogen Assessment Group, Office of Health and Environmental Assessment, Washington, DC, Report EPA/600/6-87/006.
82. EPA, 1996. Proposed Guidelines for Carcinogen Risk Assessment. US Environmental Protection Agency, Federal Register 61, Washington, DC, pp. 17960-18011.
83. Epstein, S.S., 1979. The Politics of Cancer. Anchor Press, New York.
84. Evans, J.S., Gray, G.M., Sielken, R.L. Jr, Smith, A.E., Valdez-Flores, C., Graham, J.D., 1994. Use of probabilistic expert judgment in uncertainty analysis of carcinogenic potency. Reg. Toxicol. Pharmacol. 20, 15-36.
85. FAO/WHO, 1964. Evaluation of the toxicity of pesticide residues in food. Report of a Joint Meeting of the Food and Agriculture Organization Committee on Pesticides. Agriculture and the WHO Expert Committee on Pesticide Residues, World Health Organization, Geneva (FAO Meeting Report No. PL: 1963/13; WHO/Food Add./23).
86. FAO/WHO, 1965. Evaluation of the toxicity of pesticide residues in food. World Health Organization, Geneva (FAO Meeting Report No. PL:1965/10/1; WHO Food Add./27.65).
87. FAO/WHO, 1966. Evaluation of some pesticide residues in food. World Health Organization, Geneva (FAO PPL/CP/ 15; WHO Food Add./67.32).
88. Ferrigan, L.W., Hunter, C.G., Stevenson, D.E., 1965. Observations on the effects of continued oral exposure of rats to dieldrin. Food Cosmet. Toxicol. 3, 149-151.
89. Fitzhugh, O.G., Nelson, A.A., 1947. The chronic oral toxicity of DDT (2,2-bis-p-chlorophenyl-l,l,l-trichloroethane). J. Pharmacol. Exp. Ther. 89, 18-30.
90. Fitzhugh, O.G., Nelson, A.A., Quaife, M.L., 1964. Chronic oral toxicity of aldrin and dieldrin in rats and dogs. Food Cosmet. Toxicol. 2, 551-562.
91. Floyd, R.A., 1990. Role of oxygen free radicals in carcinogenesis and brain ischemia. FASEB J. 4, 2587-2597.
92. Floyd, R.A., Watson, J.J., Wong, P.K., 1984. Sensitive assay of hydroxyl free radical formation utilizing high pressure liquid chromatography with electrochemical detection of phenol and salicylate hydroxylation products. J. Biochem. Biophys. Methods 10, 221-235.
93. Fogt, F., Nanji, A.A., 1996. Alterations in nuclear ploidy and cell phase distribution of rat liver cells in experimental alcoholic liver disease: relationship to antioxidant gene expression. Toxicol. Appl. Pharmacol. 136, 87-93.
94. Fox, T.R., Schumann, A.M., Watanabe, P.G., Yano, B.L., Maher, V.M., McCormick, J.J., 1990. Mutational analysis of the H-ras oncogene in spontaneous C57BL/6 × C3H/He mouse liver tumors and tumors induced with genotoxic and nongenotoxic hepatocarcinogens. Cancer Res. 50, 4014-4019.
95. Freeman, B.A., Crapo, J.D., 1982. Biology of disease: free radicals and tissue injury. Lab. Invest. 47, 412-426.
96. Frenkel, K., 1991. Carcinogen-mediated oxidant formation and oxidative DNA damage. Pharmacol. Ther. 53, 127-166.
97. Gavrilov, L.A., Gavrilova, N.S., 1991. The Biology of Life Span: A Quantitative Aproach. Harwood Academic, Chur, Switzerland.
98. Glauert, H.P., Schwarz, M., Pitot, H.C., 1986. The phenotypic stability of altered hepatic foci: effect of the short-term withdrawal of phenobarbital and of long-term feeding of purified diets after the withdrawal of phenobarbital. Carcinogenesis 7, 117-121.
99. Golberg, L., 1966. Liver enlargement produced by drugs, it's significance. Proceedings of the European Society for the Study of Drug Toxicity, Vol. 7, Excerpta Medica Foundation, Amsterdam, pp. 171-184.
100. Goodwin, E.S., Goulden, R., Reynolds, J.G., 1961. Rapid identification and determination of residues of chlorinated pesticides in crops by gas-liquid chromatography. J. Soc. Anal. Chem. 80, 697-700.
101. 2+ - and phospholipid-independent activation of protein kinase C by selective oxidative modification of the regulatory domain. Proc. Natl. Acad. Sci. U.S.A. 86, 6758-6762.
102. Grasl-Kraupp, B., Bursch, W., Ruttkay-Nedecky, B., Wagner, A., Lauer, B., Schulte-Hermann, R., 1994. Food restriction eliminates preneoplastic cells through apoptosis and antagonizes carcinogenesis in rat liver. Proc. Natl. Acad. Sci. U.S.A. 91, 9995-9999.
103. Grasl-Kraupp, B., Ruttkay-Nedecky, B., Mullauer, L., Taper, H., Huber, W., Bursch, W., Schulte-Hermann, R., 1997. Inherent increase of apoptosis in liver tumors: implications for carcinogenesis and tumor regression. Hepatology 25, 906-912.
104. Green, T., 1990. Species differences in carcinogenicity: the role of metabolism in human risk evaluation. Teratog. Carcinog. Mutagen. 10, 103-113.
105. Grootveld, M., Halliwell, B., 1986. Aromatic hydroxylation as a potential measure of hydroxyl-radical formation in vivo. Biochem. J. 237, 499-504.
106. Hagiwara, A., Ward, J.M., 1986. The chronic hepatotoxic, tumor-promoting, and carcinogenic effects of acetaminophen in male B6C3F1 mice. Fundam. Appl. Toxicol. 7, 376-386.
107. Halliwell, B., Kaur, H., Ingelman-Sundberg, M., 1990. Hydroxylation of salicylate as an assay for hydroxyl radicals: a cautionary note. Free Radic. Biol. Med. 10, 439-441.
108. Hassan, M.Q., Numan, I.T., Al-Nasiri, N., Stohs, S.J., 1991. Endrin-induced histological changes and lipid peroxidation in livers and kidneys of rats, mice, guinea-pigs and hamsters. Toxicol. Pathol. 19, 108-114.
109. Hayes, W.J., 1959. The toxicity of dieldrin to man. Report on a survey. Bull. World Health Org. 20, 891-912.
110. Hayes, W.J., 1982. Chlorinated hydrocarbon insecticides. In: Pesticides Studied in Man. Williams and Wilkins, Baltimore, MD, pp. 172-283.
111. Hayes, W.J. Jr, Curley, A., 1968. Storage and excretion of dieldrin and related compounds. Effect of occupational exposure. Arch. Environ. Health 16, 155-162.
112. Hayes, W.J. Jr, Laws, E.R. Jr, 1991. Handbook of Pesticide Toxicology. In: Classes of Pesticides, vol. 2. Academic Press, San Diego, CA.
113. Higginson, J., 1987. Everything is a carcinogen? Regul. Toxicol. Parmacol. 7, 89-95.
114. Hill, A.B., 1965. The environment and disease: association or causation?, Proc. R. Soc. Med., 295, 295-300.
115. Hinrichsen, L.I., Floyd, R.A., Sudilovsky, O., 1990. Is 8-hydroxydeoxyguanosine a mediator of carcinogenesis by choline-devoid diet in the rat liver? Carcinogenesis 11, 1879-1881.
116. Hodge, H.C., Boyce, A.M., Deichmann, W.B., Kraybill, H.F., 1967. Toxicology and no-effect levels of aldrin and dieldrin. Toxicol. Appl. Pharmacol. 10, 613-675.
117. Hoogendam, I., Versteeg, J.P.J., de Vlieger, M., 1962. Electroencephalograms in insecticide toxicity. Arch. Environ. Health 4, 86-94.
118. Hoogendam, I., Versteeg, J.P.J., de Vlieger, M., 1965. Nine years' toxicity control in insecticide plants. Arch. Environ. Health 10, 441-448.
119. Horio, F., Kimura, M., Yoshida, A., 1983. Effect of several xenobiotics on the activities of enzymes affecting ascorbic acid synthesis in rats. J. Nutr. Sci. Vitaminol. 29, 233-247.
120. Horio, F., Ozaki, K., Kohmura, M., Yoshida, A., Makino, S., Hayashi, Y., 1986. Ascorbic acid requirement for the induction of microsomal drug-metabolizing enzymes in a rat mutant unable to synthesize ascorbic acid. J. Nutr. 116, 2278-2289.
121. Hunt, P.F., Stevenson, D.E., Thorpe, E., Walker, A.I.T., 1975. Mouse data. Letter to the Editor. Food Cosmet. Toxicol. 13, 597-599.
122. Hunter, C.G., Robinson, J., 1967. Pharmacodynamics of dieldrin (HEOD) I. Ingestion by human subjects for 18 months. Arch. Environ. Health 15, 614-626.
123. Hunter, C.G., Robinson, J., Roberts, M., 1969. Parmacodynamics of dieldrin (HEOD). II. Ingestion by human subjects for 18 and 24 months, and post-exposure for eight months. Arch. Environ. Health 18, 12-21.
124. Hunter, J., Maxwell, J.D., Stewart, D.A., Williams, R., Robinson, J., Richardson, A., 1972. Increased hepatic microsomal enzyme activity from occupational exposure to certain pesticides. Lancet 237, 399-401.
125. Hutson, D.H., 1975. Comparative metabolism of dieldrin in the rat (CFE) and in two strains of mouse (CF1 and LACG). Food Cosmet. Toxicol. 14, 577-591.
126. Hutson, D.H., Wright, A.S., 1980. The effect of hepatic microsomal monoxygenase induction on the metabolism and toxicity of the organophosphorus insecticide chlorfenvinphos. Chem. Biol. Interact. 31, 93-101.
127. Hutterer, F., Schaffner, F., Klion, F.M., Popper, H., 1968. Hypertrophic, hypoactive smooth endoplasmic reticulum: a sensitive indicator of hepatotoxicity exemplified by dieldrin. Science 161, 1017-1019.
128. Hutterer, F., Klion, F.M., Wengraf, A., Schaffner, F., Popper, H., 1969. Hepatocellular adaptation and injury. Structural and biochemical changes following dieldrin and methyl butter yellow. Lab. Invest. 20, 455-464.
129. IARC, 1987. Evaluation of carcinogenic risk of chemicals to humans. Overall evaluations of carcinogenicity: An updating of IARC Monographs Volumes 1 to 42. International Agency for Research on Cancer, IARC Monographs, Lyon, Supplement 7.
130. Ito, N., Hananouchi, M., Sugihara, S., Shirai, T., Tsuda, H., Fukushima, S., Nagasaki, H., 1976. Reversibility and irreversibility of liver tumors in mice induced by the a isomer of 1,2,3,4,5,6-hexachlorocyclohexane. Cancer Res. 36, 2227-2234.
131. Jager, K.W., 1970. Aldrin, Dieldrin, Endrin and Telodrin: An Epidemiological and Toxicological Study of Long-term Occupational Exposure. Elsevier/North Holland, Amsterdam.
132. Jones, D.C.L., 1978. Combined effects of chemical carcinogens and other chemicals. SRI Final Report, SRI Project LSD-3478. Prepared for Tracor Jitco Inc. for the National Cancer Institute.
133. Jones, G., Butler, W.H., 1975. Morphology of spontaneous and induced neoplasia. In: Butler, W.J., Newberne, P.M. (Eds.), Mouse Hepatic Neoplasia. Elsevier/North Holland, Amsterdam, pp. 21-57.
134. Kasai, H., Nishimura, S., 1984. Hydroxylation of deoxyguanosine at the C-8 position by ascorbic acid and other reducing agents. Nucleic Acids Res. 12, 2137-2145.
135. Kauffman, S., 1995. At Home in the Universe: The Search of the Laws of Self-Organization and Complexity. Oxford University Press, New York.
136. Kehrer, J.P., 1993. Free radicals as mediators of tissue injury and disease. Crit. Rev. Toxicol. 23, 21-48.
137. Kehrer, J.P., Jones, D.P., Lemasters, J.J., Farber, J.L., Jaeschke, H., 1990. Summary of the symposium presented at the 1990 Annual Meeting of the Society of Toxicology. Toxicol. Appl. Pharmacol. 106, 165-178.
138. Kimbrough, R.D., Gaines, T.B., Linder, R.E., 1971. The ultra structure of livers of rats fed DDT and dieldrin. Arch. Environ. Health 22, 460-467.
139. Klaunig, J.E., 1991. Alterations in intercellular communication during the stage of promotion. Proc. Soc. Exp. Biol. Med. 198, 688-692.
140. Klaunig, J.E., Baker, T.K., 1994. Morphological evaluation of gap junctional intercellular communication. In: Tyson, C.A., Frazier, J.M. (Eds.), Methods In Toxicology: In Vitro Toxicity Indicators, vol. II. Academic Press, San Diego, CA, pp. 72-80.
141. Klaunig, J.E., Ruch, R.J., 1987. Strain and species effects on the inhibition of hepatocyte intercellular communication by liver tumor promoters. Cancer Lett. 36, 161-168.
142. Klaunig, J.E., Goldblatt, P.J., Hinton, D.E., Lipsky, M.M., Chacko, J., Trump, B.F., 1981. Mouse liver cell culture. I. Hepatocyte isolation. In Vitro 17, 913-925.
143. Klaunig, J.E., Siglin, J.C., Schafer, L.D., Hartnett, J.A., Weghorst, C.M., Olson, M.J., Hampton, J.A., 1991. Correlation between species and tissue sensitivity to chemical carcinogenesis in rodents and the induction of DNA synthesis. In: Butterworth, B.E., Slaga, T.J., Farland, W., McClain, R.M. (Eds.), Chemically Induced Cell Proliferation: Implications for Risk Assessment. Wiley-Liss, New York, pp. 185-194.
144. Klaunig, J.E., Bachowski, S., Ketcham, C.A., Isenberg, J.S., Kolaja, K.L., Baker, T.K., Walborg, E.F. Jr, Stevenson, D.E., 1995. Oxidative stress in nongenotoxic carcinogenesis. Toxicol. Lett. 82/83, 683-691.
145. Klaunig, J.E., Xu, Y., Isenberg, J.S., Bachowski, S., Kolaja, K.L., Jiang, J., Stevenson, D.E., Walborg, E.F. Jr, 1998. The role of oxidative stress in chemical carcinogenesis. Environ. Health Perspect. 106, 289-295.
146. Kolaja, K.L., Stevenson, D.E., Walborg, E.F. Jr, Klaunig, J.E., 1995. The effect of dieldrin and phenobarbital on preneoplastic hepatic lesion growth in male F344 rat and B6C3F1 mouse. In: McClain, R.M., Slaga, T.J., LeBoeuf, R., Pitot, H. (Eds.), Growth Factors and Tumor Promotion: Implications for Risk Assessment. Wiley-Liss, New York, pp. 409-423.
147. Kolaja, K.L., Stevenson, D.E., Johnson, J.T., Walborg, E.F. Jr, Klaunig, J.E., 1996a. Subchronic effects of dieldrin and phenobarbital on hepatic DNA synthesis in mice and rats. Fundam. Appl. Toxicol. 29, 219-228.
148. Kolaja, K.L., Stevenson, D.E., Walborg, E.F. Jr, Klaunig, J.E., 1996b. Dose-dependence of phenobarbital promotion in preneoplastic hepatic lesions in F344 rats and B6C3F1 mice: effects on DNA synthesis and apoptosis. Carcinogenesis 17, 947-954.
149. Kolaja, K.L., Stevenson, D.E., Walborg, E.F. Jr, Klaunig, J.E., 1996c. Reversibility of promoter induced hepatic focal lesion growth in mice. Carcinogenesis 17, 1403-1409.
150. Kolaja, K.L., Stevenson, D.E., Walborg, E.F. Jr, Klaunig, J.E., 1996d. Selective dieldrin promotion of hepatic focal lesions in mice. Carcinogenesis 17, 1243-1250.
151. Kolaja, K.L., Xu, Y., Walborg, E.F. Jr, Stevenson, D.E., Klaunig, J.E., 1998. Vitamin E modulation of dieldrin-induced hepatic focal lesion growth in mice. J. Toxicol. Environ. Health 53, 479-492.
152. Komiyama, T., Kikuchi, T., Sugiura, Y., 1982. Generation of hydroxyl radical by anticancer quinone drugs, carbazilquinone, mitomycin C, aclacinomycin A and adriamycin, in the presence of NADPH-cytochrome P-450 reductase. Biochem. Pharmacol. 31, 3651-3656.
153. Krewski, D., Clayson, D., Collins, B., Munro, I.C., 1982. Toxicological procedures for assessing the carcinogenic potential of agricultural chemicals. In: Fleck, R.A., Hollaender, A. (Eds.), Genetic Toxicology: An Agricultural Perspective. Plenum Press, New York, pp. 461-497.
154. Krewski, D., Wang, Y., Bartlett, S., Krishnan, K., 1995. Uncertainty, variability, and sensitivity analysis in physiological pharmacokinetic models. J. Biopharm. Stat. 5, 245-271.
155. Ku, H.-H.K., Brunk, U.T., Sohal, R.S., 1993. Relationship between mitochondrial superoxide and hydrogen peroxide production and longevity of mammalian species. Free Radic. Biol. Med. 15, 621-627.
156. Kunz, H.W., Schaude, W., Siess, M., 1966. Stimulation of liver growth by drugs. Proceedings of the European Society for the Study of Drug Toxicity, Vol. VII, International Congress Series No 115, Excerpta Medica Foundation, Amsterdam, pp. 113-153.
157. Larson, J.L., Wolf, D.C., Butterworth, B.E., 1993. Acute hepatotoxic and nephrotoxic effects of chloroform in male F344 rats and B6C3F1 mice. Fundam. Appl. Toxicol. 20, 302-315.
158. Lee, G.-H., Sawada, N., Mochizuki, Y., Nomura, K., Kitigawa, T., 1989. Immortal epithelial cells of normal C3H mouse liver in culture: possible precursor populations for spontaneous hepatocellular carcinoma. Cancer Res. 49, 403-409.
159. Linkov, I., Wilson, R., Gray, G.M., 1998a. Anticarcinogenic responses in rodent cancer bioassays are not explained by random events. Toxicol. Sci. 43, 1-9.
160. Linkov, I., Wilson, R., Gray, G.M., 1998b. Weight and survival depression in rodent bioassays with and without tumor decreases. Toxicol. Sci. 43, 10-18.
161. Lipsky, M.M., Trump, B.F., Hinton, D.E., 1989. Histogenesis of dieldrin and DDT-induced hepatocellular carcinoma in Balb/c mice. J. Environ. Pathol. Toxicol. Oncol. 9, 79-93.
162. Lombardo, P., 1991. Pesticide residues in the United States diet. In: Monitoring Dietary Intakes: ILSI Monograph Series, 1 Edn. Springer-Verlag, Berlin, pp. 183-190.
163. Loury, D.J., Goldworthy, T.L., Butterworth, B.E., 1987. The value of measuring cell replication as a predictive index of tissue-specific tumorigenic potential. In: Butterworth, B.E., Slaga, T.J. (Eds.), Nongenotoxic Mechanisms in Carcinogenesis [Banbury Report 25]. Cold Spring Harbor Laboratory, Cold Spring Harbor, pp. 119-136.
164. Lubet, R.A., Nims, R.W., Ward, J.M., Rice, J.M., Diwan, B.A., 1989. Induction of cytochrome P-450 and its relationship to liver tumor promotion. J. Am. Coll. Toxicol. 8, 259-268.
165. Mahoney, C.W., Azzi, A., 1988. Vitamin E inhibits protein kinase C activity. Biochem. Biophys. Res. Commun. 154, 694-697.
166. Malansky, C.J., Williams, G.M., 1980. Evidence for an epigenetic mode of action in organochlorine pesticide hepatocarcinogenicity: a lack of genotoxicity in rat, mouse and hamster hepatocytes. J. Toxicol. Environ. Health 8, 121-130.
167. Malarkey, D.E., Devereux, T.R., Dinse, G.E., Mann, P.C., Maronpot, R.R., 1995. Hepatocarcinogenicity of chlordane in B6C3F1 mice and B6D2F1 male mice: evidence for regression in B6C3F1 mice and carcinogenesis independent of ras proto-oncogene activation. Carcinogenesis 16, 2617-2625.
168. Mantel, N., 1974. Estimating limiting risk levels from orally ingested DDT and dieldrin using an up-dated version of the Mantel-Bryan procedure. National Technical Information Service PB-243,008, George Washington University, Washington, DC.
169. Mantel, N., Bryan, W.R., 1961. 'Safety' testing of carcinogenic agents. J. Natl. Cancer Inst. 27, 455-470.
170. Maronpot, R.R., Haseman, J.K., Boorman, G.A., Eustis, S.E., Rao, G.N., Huff, J.E., 1987. Liver lesions in B6C3F1 mice. National Toxicology Program experience and position. Arch. Toxicol. Suppl. 10, 10-26.
171. Maronpot, R.R., Fox, T., Malarkey, D.E., Goldsworthy, T.L., 1995. Mutations in the ras proto-oncogene: clues to etiology and molecular pathogenesis of mouse liver tumors. Toxicology 101, 125-156.
172. Masaki, N., Thomas, A.P., Hoekj, J.B., Farber, J.L., 1989. Intracellular acidosis protects cultured hepatocytes from the toxic consequences of a loss of mitochondrial energization. Arch. Biochem. Biophys. 272, 152-161.
173. Maskos, K., Rush, J.D., Koppenol, W.H., 1990. The hydroxylation of the salicylate anion by a Fenton reaction and G-radiolysis: a consideration of the respective mechanisms. Free Radic. Biol. Med. 8, 153-162.
174. McClain, R.M., 1990. Mouse liver tumors and microsomal enzyme-inducing drugs: experimental and clinical perspectives with phenobarbital. In: Stevenson, D.E., McClain, R.M., Popp, J.A., Slaga, T.J., Ward, J.M., Pitot, H.C. (Eds.), Mouse Liver Carcinogenesis: Mechanisms and Species Comparisons. Wiley-Liss, New York, pp. 345-365.
175. McCord, J.M., 1993. Human disease, free radicals and the oxidant/antioxidant balance. Clin. Biochem. 26, 351-357.
176. McCready, R.W., Papadimitriou, J.M., 1983. An analysis of DNA cytophotometry on tissue sections in a rat liver model. Anal. Quant. Cytol. 5, 117-123.
177. McLean, A.E.M., Driver, H.E., Sutherland, I.A., 1992. Liver tumour promotion by phenobarbital: comparison of rat and human studies. In: D'Amato, R., Slaga, T.J., Farland, W.H., Henry, C. (Eds.), Relevance of Animal Studies to the Evaluation of Human Cancer Risk. Wiley-Liss, New York, pp. 251-259.
178. Meister, A., 1992. Commentary on the antioxidant effects of ascorbic acid and glutathione. Biochem. Pharmacol. 44, 1905-1915.
179. Melchiorri, C., Chiec, P., Zedda, A.I., Coni, P., Ledda-Columbano, G.M., Columbano, A., 1993. Ploidy and nuclearity of rat hepatocytes after compensatory regeneration or mitogen-induced liver growth. Carcinogenesis 14, 1825-1830.
180. Moody, D.E., Montgomery, K.A., Ashour, M.B., Hammock, B.D., 1991. Effects of environmentally encountered epoxides on mouse liver epoxide-metabolizing enzymes. Biochem. Pharmacol. 41, 1625-1637.
181. NAS, 1993. The two-stage model of carcinogenesis. Issues In Risk Assessment, National Academy of Science. National Academy Press, Washington, DC, pp. 201-212.
182. NAS, 1994. Science and Judgment in Risk Assessment. National Academy of Science, National Research Council. National Academy Press, Washington, DC.
183. NCI, 1978a. Bioassay of aldrin and dieldrin for possible carcinogenicity. National Cancer Institute carcinogenesis Technical Report Series 21. US Department of Health, Education, and Welfare, Washington D.C., DHEW (NIH) 78-821.
184. NCI, 1978b. Bioassay of dieldrin for possible carcinogenicity. National Cancer Institute carcinogenesis Technical Report Series 22. US Department of Health, Education, and Welfare, Washington D.C., DHEW (NIH) 78-822.
185. Nerurkar, P.V., Park, S.S., Thomas, P.E., Nims, R.W., Lubet, R.A., 1993. Methoxyresorufin and benzyloxyresorufin, substrates preferentially metabolized by cytochromes P450 1A2 and 2B, respectively, in the rat and mouse. Biochem. Pharmacol. 46, 933-943.
186. Nims, L.W., Lubet, R.A., 1995. Induction of cytochrome P-450 in the Norway rat, Rattus norvegicus, following exposure to potential environmental contaminants. J. Toxicol. Environ. Health 46, 271-292.
187. NIOSH, 1978. Special occupational hazard review for aldrin/ dieldrin. National Institute for Occupational Safety and Health, Division of Criteria Documentation and Standards Development, US Department of Health, Education and Welfare, DHEW Publ. (NIOSH) 78-201.
188. 1 Mice, Technical Report No. 404. National Toxicology Program, Research Triangle Park, NC.
189. 1 Mice, Technical Report No. 439. National Toxicology Program, Research Triangle Park, NC.
190. Numan, I.T., Hassan, M.Q., Stohs, S.J., 1990. Protective effects of antioxidants against endrin-induced lipid peroxidation, glutathione depletion and lethality in rats. Arch. Environ. Contam. Toxicol. 19, 302-306.
191. Nutrition Foundation, 1983. The relevance of mouse liver hepatoma to human carcinogenic risk. Report of The International Expert Advisory Committee to The Nutrition Foundation, Washington, DC.
192. Oberholser, K.M., Wagner, S.R., Greene, F.E., 1977. Factors affecting dieldrin metabolism by rat liver microsomes. Drug Metab. Dispos. 5, 302-309.
193. Olsen, J.H., Boice, J.D. Jr, Jensen, J.P., Fraumeni, J.F. Jr, 1989. Cancer among epileptic patients exposed to anticonvulsant drugs. J. Natl. Cancer Inst. 81, 803-808.
194. Olsen, J.H., Schulgen, G., Boice, J.D. Jr, Whysner, J., Travis, L.B., Williams, G.M., Johnson, F.B., McGee, J.O., 1995. Antiepileptic treatment and risk of hepatobiliary cancer and malignant lymphoma. Cancer Res. 55, 294-297.
195. Ono, J., Mimake, T., Yabuuchi, H., 1986. Effects of phenobarbital on lipid peroxidation in vitamin E deficient rats. Pediatr. Pharmacol. 5, 223-227.
196. Ortega, P., Hayes, W.J. Jr, Durham, W.F., 1957. Pathological changes in livers of rats after feeding low levels of various insecticides. AMA Arch. Pathol. 64, 614.
197. Page, N.P., Singh, D.V., Farland, W., Goodman, J.I., Conolly, R.B., Andersen, M.E., Clewell, H.J., Frederick, C.B., Yamasaki, H., Lucier, G., 1997. Implementation of EPA revised Cancer Assessment Guidelines: incorporation of mechanistic and pharmacokinetic data. Fundam. Appl. Toxicol. 37, 16-36.
198. Parke, D.V., 1994. The cytochromes P450 and mechanisms of chemical carcinogenesis. Environ. Health Perspect. 102, 852-853.
199. Parke, D.V., Ioannides, C., 1990. Role of cytochromes P-450 in mouse liver tumor production. In: Stevenson, D.E., McClain, R.M., Popp, J.A., Slaga, T.J., Ward, J.M., Pitot, H.C. (Eds.), Mouse Liver Carcinogenesis: Mechanisms and Species Comparisons. Wiley-Liss, New York, pp. 215-230.
200. Peraino, C., Fry, R.J., Staffeldt, E., 1973. Enhancement of spontaneous hepatic tumorigenesis in C3H mice by dietary phenobarbital. J. Natl. Cancer Inst. 51, 1349-1350.
201. Peto, R., Roe, F.J.C., Lee, P.N., Levy, L., Clack, J., 1975. Cancer and aging in mice and men. Br. J. Cancer 32, 411-426.
202. Pitot, H.C., 1990. Altered hepatic foci: their role in murine hepatocarcinogenesis. Annu. Rev. Pharmacol. Toxicol. 30, 465-500.
203. Popp, J.A., 1984. Mouse Liver Neoplasia - Current Perspectives. Hemisphere Publishing Corporation, New York, NY.
204. Radi, R., Beckman, J.S., Bush, K.M., Freeman, B.A., 1991. Peroxynitrite-induced membrane lipid peroxidation: the cytotoxic potential of superoxide and nitric oxide. Arch. Biochem. Biophys. 288, 481-487.
205. Ray, J.S., Harbison, M.L., McClain, R.M., Goodman, J.I., 1994. Alterations in the methylation status and expression of the raf oncogene in phenobarbital-induced and spontaneous B6C3F1 mouse liver tumors. Mol. Carcinog. 9, 155-166.
206. Reddy, J.K., Qureshi, S.A., 1979. Tumorigenicity of the hypolipidaemic peroxisome proliferator ethyl-α-p-chlorophenoxyisobutyrate (clofibrate) in rats. Br. J. Cancer 40, 476-482.
207. Rettig, M.B., Ma, H.J., Vescio, R.A., Pold, M., Schiller, G., Belson, D., Savage, A., Nishikubo, C., Wu, C., Fraser, J., Said, J.W., Berenson, J.R., 1997. Kaposi's sarcoma-associated herpes virus infection of bone marrow dendritic cells from multiple myeloma patients. Science 276, 1851-1854.
208. Reynolds, S.H., Stowers, S.J., Maronpot, R.R., Anderson, M.W., Aaronson, S.A., 1986. Detection and identification of activated oncogenes in spontaneously occurring benign and malignant hepatocellular tumors of the B6C3F1 mouse. Proc. Natl. Acad. Sci. U.S.A. 83, 33-37.
209. Ribbens, P.H., 1985. Mortality study of industrial workers exposed to aldrin, dieldrin, and endrin. Ind. Arch. Occup. Environ. Health 56, 75-79.
210. Rice, J.M., Diwan, B.A., Ward, J.M., Nims, R.W., Lubet, R.A., 1992. Phenobarbital and related compounds: approaches to interspecies extrapolation. In: D'Amato, R., Slaga, T.J., Farland, W.H., Henry, C. (Eds.), Relevance of Animal Studies to the Evaluation of Human Cancer Risk. Wiley-Liss, New York, pp. 231-249.
211. Richardson, A., Robinson, J., 1971. The identification of a major metabolite of HEOD (dieldrin) in human faeces. Xenobiotica 1, 213-219.
212. Richardson, A., Robinson, J., Bush, B., Davies, J.M., 1967. Determination of dieldrin (HEOD) in blood. Arch. Environ. Health 14, 703-708.
213. Roberts, R.A., Nebert, D.W., Hickman, J.A., Richburg, J.H., Goldsworthy, T.L., 1997. Symposium overview. Perturbation of the mitosis/apoptosis balance: a fundamental mechanism in toxicology. Fundam. Appl. Toxicol. 38, 107-115.
214. Robinson, J., Hunter, C. G., 1966. Organochlorine insecticides: concentrations in human blood and adipose tissue. Arch. Environ. Health 13, 558-563.
215. Roe, F.J., 1981. Are nutritionists worried about the epidemic of tumors in laboratory animals? Proc. Nutr. Soc. 40, 57-65.
216. Rosenberg, L., Palmer, J.R., Zauber, A.G., Warshauer, M.E., Strom, B.L., Harlap, S., Shapiro, S., 1995. Relationship of benzodiazepine use to the risk of selected cancers: breast, large bowel, malignant melanoma, lung, endometrium, ovary, non-Hodgkin's lymphoma, testis, Hodgkin's disease, thyroid and liver. Am. J. Epidemiol. 141, 1153-1160.
217. Ruch, R.J., Klaunig, J.E., 1986. Antioxidant prevention of tumor promoter induced inhibition of mouse hepatocyte intercellular communication. Cancer Lett. 33, 137-150.
218. Ruebner, B.H., Gershwin, M.E., Hsieh, L., Dunn, P., 1980. Ultra structure of spontaneous neoplasms induced by diethylnitrosamine and dieldrin in the C3H mouse. J. Environ. Pathol. Toxicol. 4, 237-254.
219. Ruebner, B.H., Gershwin, M.E., French, S.W., Meierhenry, E., Dunn, P., Hsieh, L.S., 1984. Mouse hepatic neoplasia: differences among strains and carcinogens. In: Popp, J.A. (Ed.), Current Perspectives in Mouse Liver Neoplasia. Hemisphere Publishing, Washington, DC, pp. 115-143.
220. Sato, K., Akaike, T., Kojima, Y., Ando, M., Nagao, M., Maeda, H., 1992. Evidence of direct generation of oxygen free radicals from heterocyclic amines by NADPH/cytochrome P-450 reductase in vitro. Jpn. J. Cancer Res. 83, 1204-1209.
221. Scholz, W., Schutze, K., Kunz, W., Schwarz, M., 1990. Phenobarbital enhances the formation of reactive oxygen in neoplastic rat liver nodules. Cancer Res. 50, 7015-7022.
222. Schreck, R., Albermann, K., Baeuerle, P.A., 1992. Nuclear factor KB: an oxidative stress-responsive transcription factor of eukaryotic cells (Review). Free Radic. Res. Commun. 17, 221-237.
223. Schulte-Hermann, R.S., 1987. Tumor promotion in the liver. Arch. Toxicol. 57, 147-158.
224. Schulte-Hermann, R.S., Timmermann-Trosiener, I., Schuppler, J., 1983. Promotion of spontaneous preneoplastic cells in rat liver as a possible explanation of tumor production by nonmutagenic compounds. Cancer Res. 43, 839-844.
225. Schulte-Hermann, R.S., Bursch, W., Fesus, L., Timmermann-Trosiener, I., Krapp, B., Liehr, J., 1990. Role of cell death in hepatocarcinogenesis. In: Bannasch, P., Keppler, D., Weber, G. (Eds.), Liver Cell Cancer. Kluwer Academic Publishers, Dordrecht, pp. 339-350.
226. Schulte-Hermann, R., Bursch, W., Low-Baselli, A., Wagner, A., Grasl-Kraupp, B., 1997. Apoptosis in the liver and its role in hepatocarcinogenesis. Cell Biol. Toxicol. 13, 339-348.
227. Seglen, P.O., 1997. DNA ploidy and autophagic protein degradation as determinants of hepatocellular growth and survival. Cell Biol. Toxicol. 13, 301-315.
228. Seilkop, S.K., 1995. The effect of body weight on tumor incidence and carcinogenicity testing in B6C3F1 mice and F344 rats. Fundam. Appl. Toxicol. 24, 247-259.
229. Shibata, M.-A., Hirose, M., Kagawa, M., Boonyaphiphat, P., Ito, N., 1993. Enhancing effect of concomitant L-ascorbic acid administration on BHA-induced forestomach carcinogenesis in rats. Carcinogenesis 14, 275-280.
230. Sielken, R.L. Jr, Stevenson, D.E., 1992. Comparisons of human cancer potency projections for dieldrin based on human data with those based on animal data. In: D'Amato, R., Slaga, T.J., Farland, W.H., Henry, C. (Eds.), Relevance of Animal Studies to the Evaluation of Human Cancer Risk. Wiley-Liss, New York, pp. 295-319.
231. Sielken, R.L. Jr, Stevenson, D.E., 1994. Another flaw in the linearized multistage model upper bounds on human cancer potency. Regul. Toxicol. Pharmacol. 19, 106-114.
232. Sielken, R.L. Jr, Stevenson, D.E., 1998. Modeling to incorporate defense mechanisms into the estimation of dose responses. Environ. Health Perspect. 106, 341-348.
233. Sielken, R.L. Jr, Bretzlaff, R.S., Stevenson, D.E., de Jong, G., 1998. Updated mortality analyses of Pernis epidemiological data on human exposures to aldrin and dieldrin. Human Ecolog. Risk Assess. 4, 201-225.
234. Sielken, R.L., Jr, Bretzlaff, R.S., Valdez-Flores, C., Stevenson, D.E., de Jong, G., 1999. Cancer dose-response modeling of epidemiological data on worker exposures to aldrin and dieldrin. Risk Analysis (in press).
235. Sies, H., 1991. Oxidative stress: from basic research to clinical application. Am. J. Med. 91, 31s-38s.
236. Sies, H., Murphy, M.E., 1991. Role of tocopherols in the protection of biological systems against oxidative damage. J. Photochem. Photobiol. 8, 211-224.
237. Sigal, S.H., Gupta, S., Gebhard, D.F., Holst, P., Neufeld, D., Reid, L.M., 1995. Evidence for a terminal differentiation process in rat liver. Differentiation 59, 35-42.
238. Sohal, R.S., Sohal, B.H., Brunk, U.T., 1990. Relationship between antioxidant defense and longevity in different mammalian species. Mech. Aging Dev. 53, 217-227.
239. Song, J., Harville, W.E., 1964. Carcinogenicity of aldrin and dieldrin in mouse and rat liver. Fed. Proc. 23, 336.
240. Sorta, G., Tartaglia, L.A., Ames, B.N., 1990. Transcriptional regulator of oxidative stress inducible genes: direct activation by oxidation. Science 248, 189-194.
241. Spirduso, W.W., 1995. Physical Dimensions of Aging. Human Kinetics, Champagne, IL.
242. Standeven, A.M., Goldsworthy, T.L., 1994. Identification of hepatic mitogenic and cytochrome P-450-inducing fractions of unleaded gasoline in B6C3F1 mice. J. Toxicol. Environ. Health 43, 213-224.
243. Stevens, J.T., Oberholser, K.M., Wagner, S.R., Greene, F.E., 1977. Content and activities of microsomal electron transport components during the development of dieldrin-induced hypertrophie hypoactive endoplasmic transport. Toxicol. Appl. Pharmacol. 39, 411-421.
244. Stevenson, D.E., 1974. Written Statement, Exhibit A (Statistical analysis conducted by P.E. Hunt). US EPA Suspension Hearings on aldrin and dieldrin.
245. Stevenson, D.E., 1990. Organochlorine insecticides and mouse liver tumors: an analysis of responses and mechanisms. In: Stevenson, D.E., McClain, R.M., Popp, J.A., Slaga, T.J., Ward, J.M., Pitot, H.C. (Eds.), Mouse Liver Carcinogenesis, Mechanisms and Species Comparisons. Wiley-Liss, New York, pp. 367-383.
246. Stevenson, D.E., Walker, A.I.T., 1969. Hepatic lesions produced in mice by dieldrin and other hepatic enzyme-inducing compounds. Eur. J. Toxicol. 2, 83-84.
247. Stevenson, D.E., Thorpe, E., Hunt, P.E., Walker, A.I., 1976. The toxic effects of dieldrin in rats: a re-evaluation of data obtained in a two-year feeding study. Toxicol. Appl. Pharmacol. 36, 247-254.
248. Stevenson, D.E., Bretzlaff, R.S., Sielken, R.L. Jr, MacDonald, R.L., 1994. Dose-response characterization of life, death, and hormesis. Comments Toxicol. 5, 151-180.
249. Stevenson, D.E., Kehrer, J.P., Kolaja, K.L., Walborg, E.F. Jr, Klaunig, J.E., 1995a. Effect of dietary antioxidants on dieldrin-induced hepatotoxicity in mice. Toxicol. Lett. 75, 177-183.
250. Stevenson, D.E., Walborg, E.F. Jr, Klaunig, J.E., 1995b. The species specificity of dieldrin- or phenobarbital- induced hepatocarcinogenesis: case studies with implications for human health risk assessment. In: McClain, R.M., Slaga, T.J., LeBoeuf, R., Pitot, H. (Eds.), Growth Factors and Tumor Promotion: Implications for Risk Assessment. Wiley-Liss, New York, pp. 337-345.
251. Stinchcombe, S., Buchmann, A., Bock, K.W., Schwartz, M., 1995. Inhibition of apoptosis during 2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated tumor promotion in rat liver. Carcinogenesis 16, 1271-1275.
252. Storz, G., Polla, B.S., 1996. Transcriptional regulators of oxidative stress-inducible genes in prokaryotes and eukaryotes. EXS 77, 239-254.
253. Stowers, S.J., Wiseman, R.W., Ward, J.M., Miller, E.C., Miller, J.A., Anderson, M.W., Eva, A., 1988. Detection of activated proto-oncogenes in N-nitrosodiethylamine-induced liver tumors: a comparison between B6C3F1 mice and Fischer 344 rats. Carcinogenesis 9, 271-276.
254. Street, J.C., 1969. Organochlorine insecticides and the stimulation of liver microsome enzymes. Ann. N.Y. Acad. Sci. 160, 274-290.
255. Street, J.C., Chadwick, R.W., 1975. Ascorbic acid requirements and metabolism in relation to organochlorine pesticides. Ann. N.Y. Acad. Sci. 258, 132-143.
256. Sun, Y., 1990. Free radicals, antioxidant enzymes, and carcinogenesis. Free Radic. Biol. Med. 8, 583-599.
257. Swann, J.D., Smith, M.W., Phelps, P.C., Maki, A., Berezesky, I.K., Trump, B.F., 1991. Oxidative injury induces influx-dependent changes in intracellular calcium homeostasis. Toxicol. Pathol. 19, 128-137.
258. Talalay, P., De Long, M.J., Prochaska, H.J., 1988. Identification of a common chemical signal regulating the induction of enzymes that protect against chemical carcinogenesis. Proc. Natl. Acad. Sci. U.S.A. 85, 8261-8265.
259. Tatematsu, M., Nagamine, Y., Farber, E., 1983. Redifferentiation as a basis for remodeling of carcinogen-induced hepatocyte nodules to normal appearing liver. Cancer Res. 43, 5049-5058.
260. Teebor, G.W., Becker, F.F., 1971. Regression and persistence of hyperplastic hepatic nodules induced by N-2-fluor-enylacetamide and their relationship to hepatocarcinogenesis. Cancer Res. 31, 1-3.
261. Tennekes, H.A., Wright, A.S., Dix, K.M., 1979. The effects of dieldrin, diet and other environmental components on enzyme function and tumour incidence in livers of CF-1 mice. Arch. Toxicol. 2, 197-212.
262. Tennekes, H.A., Edler, L., Kunz, H.W., 1982. Dose-response analysis of the enhancement of liver tumour formation in CF-I mice by dieldrin. Carcinogenesis 3, 941-945.
263. Tennekes, H.A., van Ravenzwaay, B., Kunz, H.W., 1985. Quantitative aspects of enhanced liver tumour formation in CF-1 mice by dieldrin. Carcinogenesis 6, 1457-1462.
264. Tewfik, H.H., Tewfik, F.A., Riley, E.F., 1982. The influence of ascorbic acid on survival of mice following whole body X-irradiation. Int. J. Vitam. Nutr. Res. Suppl. 23, 265-276.
265. Thorpe, E., Hunt, P.F., 1975. Toxicology of dieldrin (HEOD), study of the pathological changes in 3 strains of mice following prolonged ingestion of dieldrin. Sittingbourne, Shell Research, Report TLGR.0012.75 (Unpublished proprietary report).
266. Thorpe, E., Walker, A.I., 1973. The toxicology of dieldrin (HEOD). II. Comparative long-term oral toxicity studies in mice with dieldrin, DDT, phenobarbitone, β-BHC and γ-BHC. Food Cosmet. Toxicol. 11, 433-442.
267. Torres, M., Jarvisalo, J., Hakim, J., 1981. The liver-protective enzymes against reduced forms of oxygen in phenobarbital-treated rats. Enzyme 26, 129-135.
268. Travis, C.C., Belefant, H., 1992. Promotion as a factor in carcinogenesis. Toxicol. Lett. 60, 1-9.
269. Treon, J.F., Cleveland, P.F., 1955. Toxicity of certain chlorinated hydrocarbon insecticides for laboratory animals, with special reference to aldrin and dieldrin. J. Agric. Food Chem. 3, 402-408.
270. Troll, W., Wiesner, R., 1985. The role of oxygen radicals as a possible mechanism of tumor promotion. Ann. Rev. Pharmacol. Toxicol. 25, 509-528.
271. Trosko, J.E., Goodman, J.I., 1994. Intercellular communication may facilitate apoptosis: implications for tumor promotion. Mol. Carcinog. 11, 8-12.
272. Trosko, J.E., Chang, C.C., Madhukar, B.V., Klaunig, J.E., 1990. Chemical, oncogene and growth factor inhibition of gap junctional intercellular communication: an integrative hypothesis of carcinogenesis. Pathobiology 58, 265-278.
273. Trush, M.A., Kensler, T.W., 1991. An overview of the relationship between oxidative stress and chemical carcinogenesis. Free Radic. Biol. Med. 10, 201-209.
274. Turk, P.W., Laayoun, A., Smith, S.S., Weitzman, S.A., 1995. DNA adduct 8-hydroxyl-2′-deoxyguanosine (8-hydroxyguanine) affects function of human DNA methyltransferase. Carcinogenesis 16, 1253-1255.
275. Uchiyama, M., Mihara, M., 1978. Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. Anal. Biochem. 86, 271-278.
276. US Public Health Service. Smoking and health, 1979. A report of the Surgeon General of the Public Health Service. US Department of Health and Human Services, Office on Smoking and Health. US Government Printing Office, Washington, DC.
277. van Ravenzwaay, B., Kunz, W., 1988. Quantitative aspects of accelerated nuclear polyploidization and tumour formation in dieldrin treated CF-1 mouse liver. Br. J. Cancer 58, 52-56.
278. van Ravenzwaay, B., Tennekes, H., Stohr, M., Kunz, W., 1987. The kinetics of nuclear polyploidization and tumour formation in livers of CF-1 mice exposed to dieldrin. Carcinogenesis 8, 265-269.
279. Versteeg, J.P.J., Jager, K.W., 1973. Long-term occupational exposure to the insecticides aldrin, dieldrin, endrin, and telodrin. Br. J. Ind. Med. 30, 201-202.
280. Vorce, R.L., Goodman, J.I., 1989. Hypomethylation of ras oncogenes in chemically induced and spontaneous B6C3F1 mouse liver tumors. Mol. Toxicol. 2, 99-116.
281. Wainfan, E., Poirier, L.A., 1992. Methyl groups in carcinogenesis: effects on DNA methylation and gene expression. Cancer Res. 52, 2071s-2077s.
282. Walker, A.I., Stevenson, D.E., Robinson, J., Thorpe, E., Roberts, M., 1969. The toxicology and pharmacodynamics of dieldrin (HEOD): two-year oral exposures of rats and dogs. Toxicol. Appl. Pharmacol. 15, 345-373.
283. Walker, A.I., Thorpe, E., Stevenson, D.E., 1973. The toxicology of dieldrin (HEOD). I. Long-term oral toxicity studies in mice. Food Cosmet. Toxicol. 11, 415-432.
284. Ward, J.M., Lynch, P., Riggs, C., 1988. Rapid development of hepatocellular neoplasms in aging male C3H/HeNCr mice given phenobarbital. Cancer Lett. 39, 9-18.
285. Ward, J.M., Hardisty, J.F., Hailey, J.R., Streett, C.S., 1995. Peer review in toxicologic pathology. Toxicol. Pathol. 23, 226-234.
286. Weinstein, I.B., 1991. Nonmutagenic mechanisms in carcinogenesis: role of protein kinase C in signal transduction and growth control. Environ. Health Perspect. 93, 175-179.
287. WHO, 1989. Aldrin and dieldrin. International Program on Chemical Safety, Environmental Health Criteria 91. World Health Organization, Geneva.
288. Williams, G.M., 1981. Liver carcinogenesis: the role for some chemicals of an epigenetic mechanism of liver-tumour promotion involving modification of the cell membrane. Food Cosmet. Toxicol. 19, 577-583.
289. Williams, G.M., 1990. Epigenetic mechanisms of liver tumor promotion. In: Stevenson, D.E., McClain, R.M., Popp, J.A., Slaga, T.J., Ward, J.M., Pitot, H.C. (Eds.), Mouse Liver Carcinogenesis: Mechanisms and Species Comparisons. Wiley-Liss, New York, pp. 131-145.
290. Williams, G.M., Whysner, J., 1996. Epigenetic carcinogens: evaluation and risk assessment. Exp. Toxicol. Pathol. 48, 189-195.
291. Wiseman, R.W., Stowers, S.J., Miller, E.C., Anderson, M.W., Miller, J.A., 1986. Activating mutations of the c-Ha-ras protooncogene in chemically induced hepatomas of the male B6C3F1 mouse. Proc. Natl. Acad. Sci. U.S.A. 83, 5825-5829.
292. Witz, G., 1991. Active oxygen species as factors in multistage carcinogenesis. Proc. Soc. Exp. Biol. Med. 198, 675-682.
293. Wolff, T., Greim, H., Huang, M.T., Miwa, G.T., Lu, A.Y.H., 1980. Aldrin epoxidation catalyzed by purified rat-liver cytochromes P-450 and P-448. Eur. J. Biochem. 111, 545-551.
294. Wright, A.S., Potter, D., Wooder, M.F., Donninger, C., Greenland, R.D., 1972. The effects of dieldrin on the subcellular structure and function of mammalian liver cells. Food Cosmet. Toxicol. 10, 311-332.
295. Wright, A.S., Akintonwa, D.A.A., Wooder, M.F., 1977. Studies on the interactions of dieldrin with mammalian liver cells at the subcellular level. Ecotoxicol. Environ. Saf. 1, 7-16.
296. Wright, A.S., Donninger, C., Greenland, R.D., Stemmer, K.L., Zavon, M.R., 1978. The effects of prolonged ingestion of dieldrin on the livers of male rhesus monkeys. Ecotoxicol. Environ. Saf. 1, 477-502.
297. Yamasaki, H., 1991. Gap junctional intercellular communication and carcinogenesis. Carcinogenesis 11, 1051-1058.